Xuexin Li

13PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Sequence analysisMetabolic medicineMolecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 30, 2026
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.

|Oct 20, 2025
RRM2-targeted nanocarrier enhances radiofrequency ablation efficacy in hepatocellular carcinoma through ferroptosis amplification and immune remodeling.

Weiliang Hou, Weifeng Hong, Songhua Cai

|Jun 05, 2025
Comprehensive analysis of multi-omics single-cell data using the single-cell analyst.

|May 13, 2025
Mitochondria-derived vesicles: A promising and potential target for tumour therapy.

Xueqiang Peng, Yu Gao, Jiaxing Liu

|Feb 12, 2025
Clear cell renal carcinoma essentially requires CDKL3 for oncogenesis.

Lanjing Ma, Zhongqiu Pang, Haijiao Zhang

|Dec 11, 2024
HNF4α-CDKL3 axis restricts MASLD progression by targeting FoxO1 via noncanonical phosphorylation.

Zhongqiu Pang, Hui Zhang, Shaoqin Zheng

Pageof 3

Frequent Collaborators

3 joint publications

Lu Pan

2 joint publications

Zehuan Liao

2 joint publications

Zhongqiu Pang

2 joint publications

Bufu Tang